Categories AlphaGraphs, Earnings, Health Care
LLY Earnings: Highlights of Eli Lilly’s Q2 2024 financial report
Eli Lilly and Company (NYSE: LLY) on Thursday reported a double-digit increase in revenues and profit for the second quarter of 2024. The pharma giant also raised its full-year guidance.
Worldwide revenue increased 36% annually to $11.3 billion in the June quarter, driven mainly by strong sales of Mounjaro, Zepbound, and Verzenio.
Second-quarter reported net income increased 68% from last year to $3.0 billion, or $3.8 per share. Adjusted earnings climbed 86% year-over-year to $3.92 per share.
The management raised its full-year revenue guidance to the range of $45.4 billion to $ 46.6 billion. EPS forecast and adjusted EPS forecast have been raised to $15.10-15.60 and $16.10-16.60, respectively.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
KB Home’s Q3 results expected to benefit from built-to-order model, stable demand
KB Home (NYSE: KBH) has been resilient to challenges like high mortgage rates and the inflation-induced strain on family budgets, while benefitting from the recovery in the housing market. When
Signet Jewelers (SIG) reports lower Q2 2025 sales and adj. profit
Signet Jewelers Limited (NYSE: SIG) has reported a decline in net sales and adjusted earnings for the second quarter of 2025. Same-store sales declined 3.4% during the three months. Net
Adobe reports higher Q3 revenue and earnings; results beat estimates
Design software maker Adobe Inc. (NASDAQ: ADBE) on Thursday reported an increase in third-quarter 2024 revenue and earnings. The results also topped expectations. Third-quarter revenues came in at $5.41 billion,